Lipidica, a.s. is conducting a study aimed at verifying the clinical function of the LDPC (Lipidomics Diagnostic of Pancreatic Cancer) lipidomic test and software Lipidica for the early detection of pancreatic cancer and contributing to the introduction of this non-invasive test, based on routine blood sampling, into clinical practice. The study is being conducted in the Czech Republic in the precisely defined population at increased risk of developing this disease. The study is conducted under the auspices of the Czech Gastroenterological Society in the pancreas surveillance setting and is registered on ClinicalTrials.gov, trial id NCT06549725.